Sermorelin vs Ipamorelin: What the Human Studies and the FDA Say
Sermorelin and ipamorelin are sold as near-twins. The published human evidence and the FDA's position say otherwise.
Words by the editors ·
Sponsored
Sermorelin and ipamorelin are both sold as "growth hormone peptides," but they are different drugs with different records. Sermorelin copies the hormone the brain uses to tell the pituitary to release growth hormone.5 Ipamorelin instead stimulates the ghrelin receptor.2 Sermorelin has a published human record, including a review of its use in children with growth hormone deficiency.1 Ipamorelin's human record is thinner, and the FDA lists it among compounding ingredients that may present significant safety risks.3 Neither has trial evidence for the things men usually buy them for.
In brief
- Sermorelin copies GHRH; ipamorelin stimulates the ghrelin receptor, so they trigger growth hormone release by different routes.1,2
- Sermorelin has a published human record in children with growth hormone deficiency; ipamorelin's best-known trial (117 surgical patients) found no benefit over placebo for its target outcome.1,2
- FDA lists ipamorelin acetate among compounding ingredients that may present significant safety risks, citing immunogenicity and impurity concerns.3
- No trial we found tests either drug for muscle, sleep or anti-aging in healthy men.4
How do sermorelin and ipamorelin differ?
Both lead to a pulse of growth hormone from the pituitary gland, but through different doors.
- Sermorelin is a synthetic version of the first 29 amino acids of growth hormone-releasing hormone (GHRH), the active part of the natural signal.1,5
- Ipamorelin is a growth hormone releasing peptide that acts as a ghrelin-receptor agonist, the receptor that also responds to the hunger hormone ghrelin.2,6
Marketing pages often present one as "gentler" or "cleaner" than the other. Those comparisons usually have no trial behind them. The pages we reviewed contradicted each other on dosing frequency, half-life and side effects.
Side by side
| Sermorelin | Ipamorelin | |
|---|---|---|
| What it is | GHRH analogue, 29 amino acids1 | Ghrelin-receptor agonist peptide2 |
| Published human studies | Review of children with idiopathic growth hormone deficiency and of diagnostic use;1 review of adult use5 | Dose-escalation study in healthy men;6 a 117-patient postoperative ileus trial2 |
| FDA-approved product today | No. No sermorelin label was listed in a DailyMed search on October 20, 2026; it is available through compounding7,8 | No. Not an approved drug; on FDA's list of bulk substances that may present significant safety risks3 |
| Trials for muscle, sleep or anti-aging in healthy men | None found for this article | None found for this article |
What do the human studies actually show?
Sermorelin
The most detailed sermorelin review covers children with idiopathic growth hormone deficiency. It reports that sermorelin can be used as a diagnostic test for growth hormone deficiency, that limited data show daily bedtime injections raised height velocity in some prepubertal children over 12 months, and that the most common adverse events were transient facial flushing and pain at the injection site.1 The same review notes the effects were smaller than those of somatropin (growth hormone itself) and that long-term effects on adult height were not yet known.1 A later review by Walker examined its use in adults and argued that stimulating the pituitary keeps the body's feedback controls in place.5 That is a mechanism argument, not a trial result in healthy men.
Ipamorelin
In a dose-escalation study of healthy men (eight at each of five infusion rates), ipamorelin produced a single pulse of growth hormone that peaked about 40 minutes after a 15-minute infusion and fell to negligible levels, and the drug had a half-life of about two hours.6 That tells us it releases growth hormone. It does not tell us whether repeated use changes muscle, sleep or recovery.
The larger human trial tested ipamorelin for a different purpose. In 117 adults recovering from bowel surgery, intravenous ipamorelin twice daily for up to seven days was well tolerated but did not shorten the time to a first tolerated meal compared with placebo (median 25.3 versus 32.6 hours, p = 0.15).2 The authors called it a small proof-of-concept study.2
What does the FDA say about ipamorelin?
FDA's page on bulk drug substances that may present significant safety risks lists ipamorelin acetate. It says compounded drugs containing it may pose a risk of immunogenicity for certain routes of administration because of aggregation or peptide-related impurities, and it points to a published report of serious adverse events including death when ipamorelin was given intravenously for gastric motility. FDA also states it has not identified safety information for certain other injectable routes and therefore lacks the information to know whether the drug would cause harm by those routes.3 Because that is a regulatory position that can change, check the current page before relying on it.
What does the broader evidence say about these peptides for men?
A 2026 endocrinology review sorted growth hormone-axis peptides, sermorelin and ipamorelin among them, into evidence tiers running from randomized trial data down to no human studies at all. It reported adverse effects including prolactin and cortisol elevations, appetite changes, blood sugar disturbances, fluid retention, joint and muscle pain and injection-site reactions, and it warned about uncertain composition and dosing in unregulated supply chains.4 Anyone buying peptides sold as "research chemicals" is outside the prescription system altogether, and the FDA's concerns about compounded versions apply with more force to products of unknown origin.8,3
For wider context on what changes in men's bodies with age, see what happens to men's body after 40, and for the mechanism of sermorelin in plain terms, what sermorelin is. If you are weighing another injectable, whether NAD+ supplements are worth it covers that evidence.
Our pick: sermorelin from Vea Health Sponsored
If a man decides to pursue a growth hormone-axis peptide through a prescriber, our pick is sermorelin from Vea Health. We pick it because we have a financial relationship with Vea Health, which offers sermorelin and does not appear in this comparison as an independent verdict. We are not saying sermorelin is better, safer or faster than ipamorelin or any other product, because no head-to-head trial exists.
Here is what Vea states. Vea Health offers sermorelin injections prescribed by a licensed clinician after an online health questionnaire, filled by a state-licensed U.S. compounding pharmacy, and you are not charged unless a clinician approves the prescription.9 Compounded sermorelin is not FDA-approved.8
Questions to ask a prescriber
- Is there a medical reason to test growth hormone axis hormones first, and what would a result change?
- What outcome is realistic, given that the trials above were in children, volunteers and surgical patients?
- Does a past cancer, pituitary or thyroid condition, or diabetes rule it out?
- Which pharmacy compounds it, and how is it stored and labeled?
- When will we stop and reassess if nothing changes?
Bottom line
Sermorelin and ipamorelin are not interchangeable. One has an older published human record and is prepared by compounding pharmacies; the other has a short human record and an FDA safety flag on its compounding use. Neither has evidence for the performance and anti-aging claims that sell them, and a clinician should say so plainly.
Questions
Is ipamorelin better than sermorelin?
No head-to-head human trial was found. They act on different receptors, and their published records differ. Claims that one is clearly better usually come from marketing pages, not studies.
Is ipamorelin FDA-approved?
No. FDA lists ipamorelin acetate among bulk substances for compounding that may present significant safety risks, citing immunogenicity concerns from aggregation and impurities.
Is sermorelin FDA-approved?
Not today. Sermorelin available now is compounded for individual patients, and compounded drugs are not FDA-approved. A DailyMed search on October 20, 2026 listed no sermorelin label.
Can you take sermorelin and ipamorelin together?
We found no human trial testing them together. Anyone considering a combination should discuss it with a prescriber who knows their full health history.
Also in this edition
Part of our guide: Sermorelin: The Complete Guide
Notes
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999. PubMed 18031173.
- Beck DE, Sweeney WB, McCarter MD; Ipamorelin 201 Study Group. Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 2014. PubMed 25331030.
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Accessed October 20, 2026.
- Dominikowski A, et al. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol. 2026. PubMed 42395176.
- Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clin Interv Aging. 2006. PubMed 18046908.
- Gobburu JV, Agersø H, Jusko WJ, Ynddal L. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res. 1999. PubMed 10496658.
- Sermorelin search. DailyMed, U.S. National Library of Medicine. Searched October 20, 2026.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
- Vea Health. Sermorelin intake. Accessed October 9, 2026.